Literature DB >> 24261543

DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.

Tao-wei Huang1, Jed Zaretzki, Charles Bergeron, Kristin P Bennett, Curt M Breneman.   

Abstract

Computational methods that can identify CYP-mediated sites of metabolism (SOMs) of drug-like compounds have become required tools for early stage lead optimization. In recent years, methods that combine CYP binding site features with CYP/ligand binding information have been sought in order to increase the prediction accuracy of such hybrid models over those that use only one representation. Two challenges that any hybrid ligand/structure-based method must overcome are (1) identification of the best binding pose for a specific ligand with a given CYP and (2) appropriately incorporating the results of docking with ligand reactivity. To address these challenges we have created Docking-Regioselectivity-Predictor (DR-Predictor)--a method that incorporates flexible docking-derived information with specialized electronic reactivity and multiple-instance-learning methods to predict CYP-mediated SOMs. In this study, the hybrid ligand-structure-based DR-Predictor method was tested on substrate sets for CYP 1A2 and CYP 2A6. For these data, the DR-Predictor model was found to identify the experimentally observed SOM within the top two predicted rank-positions for 86% of the 261 1A2 substrates and 83% of the 100 2A6 substrates. Given the accuracy and extendibility of the DR-Predictor method, we anticipate that it will further facilitate the prediction of CYP metabolism liabilities and aid in in-silico ADMET assessment of novel structures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261543     DOI: 10.1021/ci4004688

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  2 in total

1.  Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.

Authors:  Laura J Kingsley; Gregory L Wilson; Morgan E Essex; Markus A Lill
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

Review 2.  Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes.

Authors:  Hannu Raunio; Mira Kuusisto; Risto O Juvonen; Olli T Pentikäinen
Journal:  Front Pharmacol       Date:  2015-06-12       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.